1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and OlderInfections, respiratory system disorder, respiratory tract infectious disorder, viral infectious diseaseActive, not recruitingPhase 22025-09-09NCT07128121